Micronuclei and carcinogen DNA adducts as intermediate end points in nutrient intervention trial of precancerous lesions in the oral cavity

International Agency for Research on Cancer, 1988, Methods for Detecting DNA Damaging Agents in Human : Application in Cancer Epidemiology and Prevention Lee, 1992, Determination of biomarkers for intermediate end points in chemoprevention trials, Cancer Res, 52, 2707 Lippmann, 1990, Biomarkers as intermediate end points in chemopre- vention trials, J Natl Cancer Inst, 82, 555, 10.1093/jnci/82.7.555 Stich, 1984, Reduction with vitamin A and beta-carotenes administration of proportion of micronuc- leated buccal mucosal cells in Asian betel nut and tobacco chewers, Lancet, i, 1204, 10.1016/S0140-6736(84)91692-1 1989 National Research Council, 1982 1992 Gupta, 1980, Incidence rates of oral cancer and natural history of precancerous lesions in a 10-year follow-up study of Indian villagers, Commun Dent Oral Epidemiol, 8, 287, 10.1111/j.1600-0528.1980.tb01302.x Pindborg, 1971, Reverse smoking in Andhra Pradesh, India: a study of palatal lesions among 10,169 villagers, Br J Cancer, 25, 10, 10.1038/bjc.1971.2 Krishnaswamy, 1995, A case study of nutrient intervention of oral precancerous lesions in India, Oral Oncol, Eur J Cancer, 31, 41, 10.1016/0964-1955(94)00027-2 Stich, 1983, Quantitating the synergistic effect of smoking and alcohol consumption with the micronucleus test on human buccal mucosa cells, Int J Cancer, 31, 305, 10.1002/ijc.2910310309 Randerath, 1986, 32P post labeling test for smoking related DNA adducts in animal and human tissues, 85 Gupta, 1985, Enhanced sensitivity of 32P post labelling analysis of aromatic carcinogen—DNA adducts, Cancer Res, 45, 5656 Gupta, 1984, Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo, 81, 6943 Gupta, 1982, 32P-post labeling analysis of non-radioactive aromatic carcinogen—DNA adducts, Carcinogenesis, 3, 1081, 10.1093/carcin/3.9.1081 Johnson, 1979, The enzymatic preparation of (alpha-32P) ATP, [alpha-32P] GTP, [32P] c AMP, and their use in assay of adenylate and guanylate cyclases and cyclic nucleotide phosphodiesterases, Adv Cyclic Nucleotide Res, 10, 135 Greenwald, 1992, Keynote address: cancer prevention, Monogr Natl Cancer Inst, 12, 9 Rosin, 1983, The identification of antigenotoxic/ anticarcinogenic agents in food, 141 Parera, 1990, Macromolecular adducts and related biomarkers in biomonitoring and epidemiology of complex exposures, 164 Bartsch, 1983, Quantitative comparisons of carcinogenicity, mutagenicity and electrophilicity of 10 direct-acting alkylating agents and the initial 06:7-alkylamine ratio in DNA with carcinogenic potency in rodents, Mutat Res, 110, 181, 10.1016/0027-5107(83)90140-9 Poirier, 1984, The use of carcinogen-DNA adduct antisera for quantitation and localization of genomic damage in animal models and the human population, Environ Mutagen, 6, 879, 10.1002/em.2860060615 Wogan, 1985, Chemical and biochemical dosimetry of exposure to genotoxic chemicals, Environ Health Perspect, 62, 5, 10.1289/ehp.85625 Marshall, 1984, Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide, Nature, 310, 586, 10.1038/310586a0 Hoffmann, 1974, Comparative chemical analysis of Indian bidi and American cigarette smoke, Int J Cancer, 14, 49, 10.1002/ijc.2910140107 Mehta, 1977, Reverse smoking in Andhra Pradesh, India: variability of clinical and histological appearances of palatal changes, Int J Oral Surg, 6, 75, 10.1016/S0300-9785(77)80002-1 Beach, 1992, Human biomonitoring and the 32P-post labeling assay, Carcinogenesis, 13, 1053, 10.1093/carcin/13.7.1053 Randerath, 1991, Bulky adducts detected by 32P post labeling in DNA modified by oxidative damage in vitro. Comparison with rat lung I-compounds, Mutat Res, 250, 135, 10.1016/0027-5107(91)90169-O 1977, Oesophageal Cancer Studies on Caspian Littorol of Iran—Results of Population Studies A Prodrome, J Natl Cancer Inst, 59, 1127, 10.1093/jnci/59.4.1127